Head of the Merck Innovation Center
Head of the Merck Innovation Center
Manager Accelerator Program of Merck Group
Managing Director of PwC Strategy&
Director of Digital Health at IDEO
Deep Learning Solution Architect of NVIDIA
Principal at Flare Capital Partners
Superintendent of Taipei Medical University Hospital
Vice President of North America, Foxconn Healthcare & Bioscience Business Group
Director, Global Health and Executive Program of Aurora Medical Center Oshkosh
Founder of SimplyVital Health
Founder of Ferrum Health
Head of GCSO Innovation Development and Medical (Patient Value) Practices
CEO and Founder of Gauss Surgical
Founder of Havital HK Holdings Limited
Co-founder of IQGEN
Ph.D., Massachusetts Institute of Technology
Director of Ren Shin Wellness Park
Principal Investigator and Salk Fellow
Founder at Transplant Collective
Data Scientist at Authentic Intelligence & Junyi Academy
President and CEO at Amarex Clinical Research
Vice President at Wells Fargo Strategic Capital
Chief Technical Officer and Co-founder at Ferrum Health
Michael Gamber has worked on the development of the concept of the Innovation Center for more than three years in his role as Merck Inhouse Consultant before taking over the lead of the Innovation Center in 2015. With an academic background in business administration, information management, and business education he joined the Inhouse Consulting department of Merck in 2010. In this role, Michael worked on different projects dealing with innovation management, strategy and business process management. Prior to that Michael held different international consulting roles at PA Consulting Group, Capco, and PricewaterhouseCoopers. Michael received his diploma from the University of Mannheim in 2005.
Hong joint the Innovation Center of Merck as an MBA fellow of the Collége des Ingeniéurs in 2016. Since then he supported the development of the external activities including the Accelerator and Hackathons. He focuses now on managing the Accelerator Program with its major objective to find the right collaboration partner for Merck. Furthermore, he is involved in setting up the Merck China Accelerator in Shanghai. Hong holds a double degree MSc. in Business Administration and Mechanical Engineering from RWTH Aachen and Tsinghua University. Hong has a Chinese origin and was born and grew up in Germany.
Brian Williams has nearly twenty years of investment, business development, and strategy expertise within the healthcare industry. As a member of PwC
Strategy&’s healthcare team, Brian advises the senior executives of traditional medical device and diagnostics companies about the healthcare industry’s evolution into the “New Health Economy.” Prior to joining PwC, Brian was an executive at two healthcare companies, including one early-stage business for which he quadrupled revenues in three years, leading to the sale of the company for ten times its invested capital.
Pablo is the Director of Digital Health at IDEO. He partners with startups and global corporations alike to develop digital products and services at the intersection of health and other industries, such as mobility, retail, and education. Pablo was selected in the Forbes 30 Under 30 list in healthcare in 2016. He is also an endeavor entrepreneur and has mentored several other startups. Pablo holds a Master’s degree in Business Administration.
Andrew Liu is a senior deep learning solution architect at NVIDIA, assist customers in building innovative solutions based on NVIDIA technology. His research interests are in the area of applying machine learning algorithms to real-world problems. Prior to NVIDIA, Andrew was a machine learning engineer at Foxconn. He took the lead of the analytical team, developed various kinds of predictive modeling projects centered around manufacturing processes, including defect inspection and predictive maintenance, etc. During the Ph.D. program, he has worked as a visiting scholar at Los Alamos National Laboratory's BioScience Team, working on Human and Environmental Microbiome Projects.
Dan Gebremedhin is a Principal at Flare Capital Partners where he focuses on identifying early-stage companies that harness technology. Prior to joining Flare, Dan served as the Associate Medical Director at the Harvard Pilgrim Health Plan, focusing on Population Health Analytics and Value-Based Purchasing. Dan is a practicing Internal Medicine Physician on the Faculty of the Massachusetts General Hospital, and has an appointment as an Instructor at Harvard Medical School. Previously, Dan spent time as an entrepreneur and operator in the Health IT Industry, co-founding and managing two separate businesses in the Electronic Health Records and Online Medical Education industries.
Ray-Jade is the current Superintendent of Taipei Medical University, he is also a professor of surgery at Taipei Medical University. He served as the Executive Director of the Taipei Medical University Management Development Center. His research interests focus on hepatobiliary and pancreatic surgery, acute surgery, trauma epidemiology, critical care and medical information, etc. He emphasized that the global industry is undergoing a transformation. In the foreseeable future, personalized medicine is bound to become the mainstream of the healthcare industry.
Charlie is a skilled and experienced executive with a successful track record of growing multiple U.S. early-stage healthcare and hospital technology firms into thriving and valuable companies. He has deep domain expertise in the medical device and cloud-based technology has led to multiple exits that provided exceptional shareholder value. He also directly led the recruitment of over $200M of financial investment which supported business transitions from technology innovation to profitable commercialization. In his previous role, Charlie headed Sotera Wireless’ U.S. sales and marketing. In 2017, Foxconn Corporation became the majority shareholder in Sotera Wireless. He joined the Foxconn Health Technology Group to become the Vice President of North America to launch Foxconn’s entry & expansion into the US Healthcare market.
Dr. Bijoy Khandheria is a cardiologist in Milwaukee, Wisconsin and is affiliated with multiple hospitals in the area, including Aurora Medical Center of Oshkosh and Aurora St. Luke's Medical Center. He received his medical degree from Baroda Medical College and has been in practice for more than 20 years.
Kat is co-founder and CEO of SimplyVital Health, a blockchain solution to problems in medical recordkeeping and healthcare payment systems. Fortune Magazine named her among the 34 Leaders Who Are Changing Health Care. She founded the company as a solution for problems she faced as a hospital administrator. Solutions include support for data security, care-coordination, post-hospital data, communications, and analytics for decision making and risk management. Prior to founding SimplyVital Health, Katherine was the Program Manager of the Center for Musculoskeletal Care for Yale New Haven Health. She was also a strategic planner for the medicine and surgery service lines at Yale New Haven Health and designed an enterprise-wide care management dashboard at a statewide community health center network.
Pelu is the Cofounder of Augmedix and Ferrum, healthcare technology startups based in San Francisco dedicated to improving patient care. He is a member of the World Economic Forum Technology Pioneers, a Fellow at the UN World Summit on Innovation, a member of the Forbes Healthcare 30 under 30, an Aspen Institute Scholar, and a Johns Hopkins CTY Distinguished Alumni. Pelu has guest lectured at UC Berkeley, UCSF, and Stanford on healthcare leadership and innovation.
Disa has 15+years of experience working in technology and innovation especially in the pharmaceutical industry. In her current role as Director Head of Innovation within the Global Clinical Sciences & Operations (GCSO) group at UCB, she is responsible for evaluating, piloting, and implementing innovative solutions in clinical trials. Prior to joining the pharmaceutical industry, she was a co-founder of an IT company. She has an EMBA and B.S. in Pharmaceutical Chemistry. Disa started and co-leads a cross-industry collaboration on blockchain via PhUSE.
Siddarth Satish is the CEO and founder of Gauss Surgical, a firm which develops real-time blood monitoring solutions to provide an accurate and objective estimation of blood loss to help optimizing transfusion decisions, recognizing hemorrhage status and improving patient outcomes. He was named to Forbes Healthcare 30 under 30 in 2018 by developing an FDA-cleared app to monitor blood loss in the Operating Room to make childbirth safer.
Melissa Yu aspires to advance the health and well-being of people through her products and ideas. Spurred on by personal experience, she has focused on the research and development of products that aim to fight against conditions such as liver cancer and Alzheimer's. So far, she has been a part of the international market development of two natural remedies that help combat both diseases. She was named to Forbes 30 Under 30 - Asia - Healthcare & Science 2018.
Aman is a healthcare visionary. In his professional career spanning over 8 years, he has had diverse working experience from academia, to mid-cap biotech to public-private research organization funded by all major Pharma companies and numerous healthcare based startups. Aman is currently the Founder and Managing Partner of one of Asia’s leading Health tech-focused investment and advisory firms IQGEN looking to invest in countries like Japan, Malaysia, Taiwan, Indonesia, Thailand, besides South Asia and the Middle East. He was nominated as Prime Minister’s Top 40 under 40 emerging entrepreneurs of Canada to NextFounders, and member of the Executive Club of Canada.
Leon is an assistant professor at the University of California, San Diego, with appointments in the linguistics department and the Halıcıoğlu Data Science Institute. He was a postdoc at Stanford University and received his Ph.D. from MIT's Brain and Cognitive Sciences department. Leon uses computational modeling and experimental methods to study linguistic phenomena.
Chrissy Wang is a passionate and fearless American Taiwanese who's transitioned from no exercise at all to being the first woman in Taiwan to complete the Big Six World Marathon Majors. She has had 15 years of healthcare management experience and in 2017, using her passion and drive for all things in her life, she's created Ren Shin Wellness Park, offering a refreshing take on long-term care. The Wellness Park has been named "the new benchmark for long-term care in Taiwan" .
Patrick Hsu is a Principal Investigator at the Salk Institute for Biological Studies, where his lab develops and applies next-generation genome engineering technologies. Recently, the Hsu lab discovered and developed novel CRISPR systems that expand the genome editing toolbox beyond DNA to RNA. Working with Feng Zhang at the Broad Institute of MIT and Harvard, he contributed to the early development of CRISPR-Cas9. At Editas Medicine, Patrick also previously led preclinical discovery projects to translate these tools for treating human genetic disorders. He has been recognized for these contributions by Forbes' 30 Under 30 and the NIH Director's Early Independence Award.
Yi-Min is the Head of Visual Content at Doximity. As a medical illustrator and designer, she drives the intersection of art and science for the largest HIPAA-secure medical network in the United States, with over 70% of US physicians as members. Doximity helps physicians securely connect and collaborate on patient care, referrals, research, education, and careers. Her former background as a kidney transplant researcher also led her to found Transplant Collective, an online resource assisting kidney patients in post-transplant recovery through educational videos and newsletter content.
Dr. Wu is a board certificated specialist in rehabilitation medicine. He previously practiced at the rehabilitation department of the National Taiwan University Hospital and is currently a data scientist at Authentic Intelligence and Junyi Academy. Dr. Wu's research topics include data democratization within organizations and behavior change with data-driven approaches. In 2016, his team was awarded the first prize on the topic "Integrated Detection Service for Dysphagia Patients" in first MEDx LIVE. He won first prize at the first Tai-power Hackathon on the topic "Relationship between geographic location and electricity consumption". In 2017, he won the Taiwan Medical Information Society's blockchain hackathon for “Using blockchain to solve the problem of patient subsidies and donations".
Dr. Kazempour, President & CEO of Amarex Clinical Research, has over 30 years of clinical development experience including working within the US FDA as a reviewer, working in the pharmaceutical industry, and representing to US FDA all Amarex clients seeking product approval. While working at FDA, he received awards for innovative problem solving and teamwork, also for his contributions to the drug approval process. Dr. Kazempour had served as Global Biometrics Senior Director for an international pharmaceutical company and he was responsible for implementing International Council for Harmonisation (ICH) guidelines and validating the programs for all biometrics offices. He has spent many years focusing on international drug and device development and assisted Asian clients for the submission of IND, IDE, 505(b)2, 510k, PMA, BLA and NDA.
Christine Guo is an early stage healthcare investor and founding member of the Wells Fargo Strategic Capital healthcare team. Wells Fargo Strategic Capital is the venture capital and growth equity arm of Wells Fargo, the world’ s second-largest bank by market capitalization. Prior to joining Wells Fargo, Christine was previously at Collective Health, New Enterprise Associates, and Goldman Sachs. She graduated from Harvard Business School and the University of Pennsylvania.
Kenneth Ko leads a team of engineers building the next generation of healthcare infrastructure.
Ferrum provides a HIPAA-compliant, enterprise-grade, edge computing platform used by hospitals
around the world to deploy machine learning algorithms on their patient data. Prior to Ferrum, Ken
spent close to a decade developing enterprise infrastructure with global technology leaders like Cisco
Systems and Harmonic. At Cisco, Ken designed and developed the network analytics and monitoring
tools used by the majority of Fortune 500 companies. At Harmonic, Ken’s team designed and
developed the distributed storage systems used by CNN, BBC, and other international news
agencies to manage and distribute petabytes of video and content across the world.
Dr. Huang, graduated from Department of Medicine, China Medical University in 2003. He started his service in the Emergency Department of MacKay Memorial Hospital in 2005, and currently serves as a senior attending physician in the emergency department of MacKay. Huang was once an adjunct instructor at Yuanpei University of Medical Technology and is now an adjunct instructor in the Department of Medicine MacKay Medical College. Dr.Huang is an emergency physician, specialist of critical care in Gerontology, and an ACLS instructor.
Dr. Lin is a motivated and competent board certificated emergency physician with years of clinical experience. Familiar with medical technology commercialization, especially clinical study design, FDA regulation, IP strategy, and U.S./Taiwan reimbursement policy. Aim to translate the unmet clinical needs into diagnostic and therapeutic approaches.
Shih-Ming Chu, a guitarist of two bands, "Maffine" and "Mr. Pineapple Band". He has made several work and planned several tours, Tokyo being the farthest.
Chu graduated from the Department of Medicine of National Taiwan University, he used to be that cool kid in his class who didn’t put so much effort in what people saw as students’ duties, but more in developing his interests and making music. He gets excited whenever he meets band lovers. Chu hopes that indie bands can be heard by more people.
Yung-Cheng Shin, Ph.D., Department of Biochemistry and Technology, National Taiwan University, majored in basic biochemistry and immunology. During his school days, Shin served as a teaching assistant in both biochemistry experiments and biotechnology core techniques. The target students ranged from high school students to doctoral students. He is currently a co-founder and head of the trading team at Yingtrade Capital, using quantitative trading design in the field of auto trading program and applying them to financial goods transactions in reality.
William Hu is the development manager of Acusense Biomedical Company and the PhD student of BME in NCKU. He is also the co-founder of H.I.T. for Asia and the CEO of H.I.T. for Asia X NCKU. He used to be the chairman in Department of Life Science in Yang-Ming University and chairman in Department of Biomedical Electronics and Bioinformatics in National Taiwan University. Hu is passionate about biomedical innovation and exploring career in biomedical field, wanting to become a biomedical entrepreneur to activate biomedical industry ecosystem in Taiwan.
Jimmy Ming-Yuan Huang received his M.D. in 2000, finished residency program in Emergency Medicine, currently serves as Senior Consultant and as a leader of digital medicine at Center of Biomedical Development, Innovation and Incubation at MacKay Memorial Hospital. Dr. Huang’s research interest includes next-generation healthcare, with focus on mHealth and telehealth to facilitate patient engagement for people with chronic diseases, rapid development and scaling of conceptual prototypes that integrate IoT features into medical devices, educational technology using virtual/ augmented reality and mobile learning to enrich the experience in medical education, IT-enhanced tools for data processing and visualization that help patient-physician communication in clinical medicine. He is currently exploring the subjects using clinical trials as well as data technology in both MacKay Memorial Hospital and MacKay Medical College.
Yueh-Feng Hsieh, graduated from the School of Chinese Medicine of China Medical University, holding a double license for Chinese and Western medicine. Hsieh used to work at Chang Gung Memorial Hospital, currently serves as the Superintendent of Tianyitang Traditional Chinese Medicine Clinic, and a doctor of Auntie Postpartum Nursing Care Center. Dr. Hsieh is also a director of the World Federation of Chinese Medicine Societies, a medical consultant of Golden Horse Film Academy, and a distinguished doctor of the 2017 Summer Universiade.
Cara Huang is the founder of Myofascial Guasha Analysis (MGA) and a physical therapist. Due to her being the 3rd generation in her family to practice Chinese medicine, her master thesis was to research the effectiveness of Gua Sha in treatments. In order to establish the fundamentals of Gua Sha, she now is a PhD student in National Taiwan University. Her future doctoral studies will be to incorporate clinical reasoning and evidence-based Gua Sha theories in treatments. Her dream is to build up and promote the MGA system to people around the world.
Ani Hsieh, established Taiwan patient community ”aboutSick” and her fan page “Hiphopani.” She is a UI designer, becoming a sparetime rapper after diagnosed with cancer. Hsieh is currently dedicating to the field of medicine as well as Social Network Services, hoping to do her share of help to those suffering from cancer.